Viking Therapeutics Stock Forum

$Viking Therapeutics (VKTX.US)$
Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
Viking Therapeutics (NASDAQ: VKTX) has completed enrollment in its Phase 2 VENTURE-Oral Dosing Trial of VK2735, a dual GLP-1 and GIP receptor agonist tablet for obesity treatment. The 13-week study enrolled 280 adults with BMI ≥30 kg/m2 or BMI ≥27 kg/m2 with weight-related conditions.
The trial's primary endpoint foc...

$Viking Therapeutics (VKTX.US)$
Major Milestone: Viking's Oral Weight Loss Drug Advances with 280-Patient Phase 2 Trial

$Viking Therapeutics (VKTX.US)$
👇🏻🔬🔬🔬🧫🧫🧫💊💊💊🧮🧮🧮🚀🚀🚀
fiercepharma.co...

Here are the levels to watch on VKTX today. Under 27.02 decent open space on the way down to the 24.83.
$Viking Therapeutics (VKTX.US)$  

$Viking Therapeutics (VKTX.US)$
Viking Therapeutics Locks Massive GLP-1 Supply Deal: Game-Changing Partnership Covers Both Oral and Injectable Forms

$Viking Therapeutics (VKTX.US)$
Viking's Game-Changing Manufacturing Deal Powers Billion-Dollar Obesity Drug Ambitions

$Viking Therapeutics (VKTX.US)$ if this is your first time investing in biotech, you will need some perspective here. the share price is largely influenced by marginal buyers and sellers, and in this case, price action favors sell side. However, in the long run, holding and adding to your position with conviction WILL pay off.

$Viking Therapeutics (VKTX.US)$ shareholder value materializing behind the scenes. buyback authorized & pfizer m&a interest rumor may have meat here.